SFDA Approves Roche's Avastin As First Anti-angiogenesis Cancer Treatment
This article was originally published in PharmAsia News
Executive Summary
Roche China announced on May 7 that China's State FDA has approved Avastin (bevacizumab) for the treatment of metastatic colorectal carcinoma